Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1989-09-20
1991-10-22
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
514 49, 424 854, 424 855, 424 857, C07H 1906, A61K 3766
Patent
active
050594184
ABSTRACT:
A method of treating patients having viral infections exhibiting a synergistic antiviral effect in combination therapy of viral infections is comprised of combining synergistically effective amounts of a halogenated pyrimidine and human recombinant interferon-beta, said agents to be delivered separately or as a single combined composition of matter.
REFERENCES:
patent: 4289689 (1981-09-01), Friesen et al.
patent: 4588585 (1986-05-01), Mark et al.
patent: 4666892 (1987-05-01), Fox et al.
Hu et al., J. Biol. Resp. Mod. 6:121-129 (1987).
Melvin D. Trousdale et al., "Activity of 1-(2'-Fluoro-2'-Deoxy-.beta.-D-Arabinofuranosyl) Thymine Against Herpes Simplex Virus in Cell Cultures and Rabbit Eyes", Antimicrobial Agents and Chemotherapy 23(6): 808-813 (Jun. 1983).
Raymond F. Schinazi et al., "Therapeutic Activities of 1-(2-Fluoro-2-Deoxy-.beta.-D-Arabinofuranosyl)-5-Iodocytosine and -Thymine Alone and in Combination with Acyclovir and Vidarabine in Mice Infected Intracerebrally with Herpes Simplex Virus", Antimicrobial Agents and Chemotherapy 24(1): 95-103 (Jul. 1983).
Deborah A. Eppstein et al., "Patent Synergistic Inhibition of Herpes Simplex Virus-2 by 9-[(1,3-Dihydroxy-2-propoxy)methyl] quanine in Combination with Recombinant Interferons", Biochemical and Biophysical Research Communications 120 (1): 66-73 (Apr. 16, 1984).
Ting-Chao Chou et al., "Quantitative Analysis of Dose-Effect Relationshps: The Combined Effects of Multiple Drugs or Enzyme Inhibitors", Advances in Enzyme Regulation, George Weber editor, 22: 27-55 (1983).
Michael P. Fanucchi et al., "Phase I Trial of 1-(2'-Deoxy-2'-Fluoro-1-.beta.-D-Arabinofuranosyl)-5-Methyluracil (FMAU)", Cancer Treatment Reports 69(1): 55-59 (Jan., 1985).
J. J. Fox et al., "Antiviral Activities of Some Newer 2-'Fluoro-5-Substituted Arabinosylpyrimidine Nucleosides", Herpes Viruses and Virus Chemotherpay, R. Kono and A. Nakajima editors, pp. 53-56 (1985).
Donald R. Mayo et al., "Treatment of Primary Acute Genital Herpes in Guinea Pigs by Intraperitoneal Administration of Fluoroyrimidines", Antimicrobial Agents and Chemotherapy 26(3): 354-357 (1984).
Kenneth F. Soike et al., "Activity of 1-(2'-Deoxy-2'-Fluoro-.beta.-D-Arabinofuranosyl)-5-Iodouracil Against Simian Varicella Virus Infections in African Green Monkeys, Antimicrobial Agents and Chemotherapy" 29(1): 20-25 (Jan. 1986).
Ting-Chao et al., "Synthesis and Biological Effects of 2'-Fluoro-5-Ethyl-1-.beta.-D-Arabinofuranosyluracil", Antimicrobial Agents and Chemotherapy 31(9): 1355-1358 (Sep. 1987).
Kenneth F. Soike et al., "Effect of 9-(1,3-Dihydroxy-2-Propoxymethyl) Guanine and Recombinant Human .beta. Interferon Alone and in Combination on Simian Varicella Virus Infection in Monkeys", The Journal of Infectious Diseases 156(4): 607-614 (Oct. 1987).
Dow Karen Babyak
Guest Shelly J.
Jecminek Al A.
Moskowitz Margaret
Precivale Shelley G.
LandOfFree
Synergistic effect of human recombinant interferon-beta on halog does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic effect of human recombinant interferon-beta on halog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic effect of human recombinant interferon-beta on halog will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-107120